Clinical Trial Update: R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-CHOP-14 versus R-CHOP-21 with Darbepoetin alfa in patients aged 60-80 with diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CHOP-14
• R-CHOP-21
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Diffuse Large Cell Lymphoma | Phase 3 | Status: COMPLETED